 Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla. , March 24, 2022 PRNewswire -- INVO Bioscience, Inc. NASDAQ: INVO, a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell medical device and the IVC procedure it enables, will report financial results for its fourth quarter and fiscal year 2021, ended December 31, 2021, after the market close on Thursday, March 31, 2022. 